<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2218-3620</journal-id>
<journal-title><![CDATA[Revista Universidad y Sociedad]]></journal-title>
<abbrev-journal-title><![CDATA[Universidad y Sociedad]]></abbrev-journal-title>
<issn>2218-3620</issn>
<publisher>
<publisher-name><![CDATA[Editorial "Universo Sur"]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2218-36202022000500133</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Aprendizajes de la gestión de I+D+I biofarmacéutica cubana: caso de empresa de alta tecnología]]></article-title>
<article-title xml:lang="en"><![CDATA[Cuban biopharmaceuticals R &amp; D &amp; I management learnings: case of high technology company]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgado Fernández]]></surname>
<given-names><![CDATA[Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Escuela Superior de Cuadros del Estado y del Gobierno (ESCEG)  ]]></institution>
<addr-line><![CDATA[ La Habana]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2022</year>
</pub-date>
<volume>14</volume>
<numero>5</numero>
<fpage>133</fpage>
<lpage>141</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2218-36202022000500133&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2218-36202022000500133&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2218-36202022000500133&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La Investigación, Desarrollo e innovación (I+D+i) biofarmacéutica se caracteriza por una baja probabilidad de éxito, elevados tiempo y costos para su introducción en el mercado en entornos muy regulados con elevados estándares, constituyendo un reto a vencer por las empresas del sector, que requiere la adopción de enfoques integrados de la gestión de la innovación que satisfagan las necesidades de esta industria. El artículo tiene como objetivo exponer las características de la gestión biofarmacéutica a nivel internacional y en Cuba, evidenciar su complejidad, los retos y diversos aprendizajes obtenidos en la gestión de la investigación, desarrollo e innovación (I+D+i) biofarmacéutica cubana. Para ello se presentan los resultados alcanzados en algunos de los proyectos de innovación de los principales directivos del Grupo empresarial BioCubaFarma durante su superación en la Escuela Superior de Cuadros del Estado y del Gobierno. En particular, se muestran las innovaciones organizacionales en el Centro de Inmunología Molecular como caso de estudio de empresa de alta tecnología. El método seguido para el diagnóstico, el uso de la prospectiva y las encuestas de innovación, así como en la generación de los proyectos de innovación pueden ser generalizables a otros sistemas empresariales del país.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Biopharmaceutical Research, Development and Innovation (R&amp;D&amp;i) is characterized by a low probability of success, high time and costs for its introduction to the market in highly regulated environments with high standards, constituting a challenge to be overcome by companies in the sector, which requires the adoption of integrated approaches to innovation management that meet the needs of this industry. The article aims to explain the characteristics of biopharmaceutical management at the international level and in Cuba, highlighting its complexity, the challenges and various lessons learned in the management of Cuban biopharmaceutical research, development and innovation (R&amp;D&amp;I). For this, the results achieved in some of the innovation projects of the main directors of the BioCubaFarma business group are presented during their graduation at the Higher School of State and Government Cadres. In particular, organizational innovations at the Center for Molecular Immunology are shown as a high-tech company case study. The method followed for the diagnosis, the use of prospective and innovation surveys, as well as in the generation of innovation projects can be generalized to other business systems in the country.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[I+D+i]]></kwd>
<kwd lng="es"><![CDATA[Gestión de I+D+i]]></kwd>
<kwd lng="es"><![CDATA[Biofarmacéutica]]></kwd>
<kwd lng="es"><![CDATA[Innovación]]></kwd>
<kwd lng="es"><![CDATA[Proyecto de innovación]]></kwd>
<kwd lng="es"><![CDATA[Calidad]]></kwd>
<kwd lng="en"><![CDATA[R&amp;D&amp;I]]></kwd>
<kwd lng="en"><![CDATA[R&amp;D&amp;I management]]></kwd>
<kwd lng="en"><![CDATA[Biopharmaceutical]]></kwd>
<kwd lng="en"><![CDATA[Innovation]]></kwd>
<kwd lng="en"><![CDATA[Innovation project]]></kwd>
<kwd lng="en"><![CDATA[Quality]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agrawal]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biopharmaceuticals: An emerging trend in Drug Development]]></article-title>
<source><![CDATA[SOJPharm Pharmaceut Sci.]]></source>
<year>2015</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antúnez]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modelo de gestión integrada de la calidad en la industria biofarmacéutica cubana. Experiencias de su aplicación en dos organizaciones del sector.]]></article-title>
<source><![CDATA[Cofín Habana]]></source>
<year>2018</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bengt- Åke]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Learning Economy and the Economics of Hope]]></source>
<year>2016</year>
<page-range>423</page-range><publisher-loc><![CDATA[Londom ]]></publisher-loc>
<publisher-name><![CDATA[Anthem Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro-Díaz-Balart]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Project Management para la gestión de la innovación en la Industria cubana.]]></article-title>
<source><![CDATA[Revista Bimestre Cubano]]></source>
<year>2000</year>
<volume>88</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>169-202</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tendencias en los sistemas de gestión de calidad en la I+D biofarmacéutica]]></article-title>
<source><![CDATA[Biotecnología Aplicada]]></source>
<year>1998</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Arrebato]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico integrado de la vigilancia tecnológica en organizaciones]]></article-title>
<source><![CDATA[Ingeniería Industrial]]></source>
<year>2011</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>151-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfoque para la gestión de la I+D+i en la Industria Biofarmacéutica cubana]]></article-title>
<source><![CDATA[Revista Cubana de Información en Ciencias de la Salud.]]></source>
<year>2017</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovación Empresarial]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Coordinador académico. Temas de Gestión Empresarial]]></source>
<year>2017</year>
<volume>II</volume>
<page-range>117</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Universitaria Félix Varela]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proyectos de innovación en Administración Pública y Empresarial en Cuba]]></article-title>
<source><![CDATA[Folletos gerenciales]]></source>
<year>2018</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>71-84</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lage]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ojito]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Visión de la innovación en un centro cubano de la biotecnología aplicada a la salud]]></article-title>
<source><![CDATA[Revista Cubana de Salud Pública]]></source>
<year>2020</year>
<volume>46</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso del diseño de experimentos para la innovación empresarial]]></article-title>
<source><![CDATA[Revista de métodos cuantitativos para la economía y la empresa]]></source>
<year>2020</year>
<volume>Junio</volume>
<numero>29</numero>
<issue>29</issue>
<page-range>38-56</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delerue]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sicotte]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resource interdependence and project termination: An analysis in the biopharmaceutical industry.]]></article-title>
<source><![CDATA[International Journal of Project Management]]></source>
<year>2020</year>
<volume>38</volume>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Canel]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestión del gobierno orientado a la innovación: Contextoy caracterización del Modelo.]]></article-title>
<source><![CDATA[Revista Universidad y Sociedad]]></source>
<year>2021</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-16</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<collab>EFPIA</collab>
<source><![CDATA[The Pharmaceutical Industry in Figures Key Data 2021]]></source>
<year>2021</year>
<publisher-name><![CDATA[European Federation of Pharmaceutical Industries and Associations (EFPIA)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lage]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución de la gestión organizacional en un centro cubano de la biotecnología]]></article-title>
<source><![CDATA[Ingeniería Industrial]]></source>
<year>2017</year>
<volume>38</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>311-22</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farid]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Stamatis]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Nie]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Coffman]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&amp;D]]></article-title>
<source><![CDATA[mAbs]]></source>
<year>2020</year>
<volume>12</volume>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[T.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[B.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Model-based drug development: application of modeling and simulation in drug development.]]></article-title>
<source><![CDATA[Journal of Pharmaceutical Investigation]]></source>
<year>2017</year>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohara]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Barriers of Knowledge in Biopharmaceutical Research and Development in Japan]]></article-title>
<source><![CDATA[Journal of Commercial Biotechnology]]></source>
<year>2018</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>24-40</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poplazarova]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zee]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Breuer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethical decision-making in biopharmaceutical research and development: applying values using the TRIP &amp;TIPP model]]></article-title>
<source><![CDATA[Human Vaccines &amp; Immunotherapeutics]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wise]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Grebe]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Splendiani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Balali-Mood]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Vasant]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementation and relevance of FAIR data principles in biopharmaceutical R&amp;D]]></article-title>
<source><![CDATA[Drug Discovery Today]]></source>
<year>2019</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>933-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
